APA (7th ed.) Citation

Shinya, H., Ryuichi, S., Makito, Y., Konosuke, M., Takahiro, M., & Lay-Myint, Y. (2019). 1g versus 2g Daily Intravenous Ceftriaxone in the Treatment of Community Onset Pneumonia –a propensity score analysis of data from a Japanese multicenter registry. BMC Infectious Diseases, 19, . https://doi.org/10.21203/rs.2.10421/v1

Chicago Style (17th ed.) Citation

Shinya, Hasegawa, Sada Ryuichi, Yaegashi Makito, Morimoto Konosuke, Mori Takahiro, and Yoshida Lay-Myint. "1g Versus 2g Daily Intravenous Ceftriaxone in the Treatment of Community Onset Pneumonia –a Propensity Score Analysis of Data from a Japanese Multicenter Registry." BMC Infectious Diseases 19 (2019). https://doi.org/10.21203/rs.2.10421/v1.

MLA (9th ed.) Citation

Shinya, Hasegawa, et al. "1g Versus 2g Daily Intravenous Ceftriaxone in the Treatment of Community Onset Pneumonia –a Propensity Score Analysis of Data from a Japanese Multicenter Registry." BMC Infectious Diseases, vol. 19, 2019, https://doi.org/10.21203/rs.2.10421/v1.